Clinical Research Directory

Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

Sponsor: National Cancer Institute (NCI)

Summary

Background: The NCI Surgery Branch has developed experimental therapies that involve taking white blood cells from participants' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective: This study will allow participants to be followed for up to 15 years following treatment on an NCI Surgery Branch Gene Therapy Trial as required by the FDA. Eligibility: Participants must have been enrolled on an NCI Surgery Branch Gene Therapy Protocol Design Participants will be followed with a physical examination and blood tests for up to 15 years as required by the FDA

Official title: Follow-Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

Key Details

Conditions

Locations (1)